Shanti Overseas (India) Ltd (SHANTI) — shareholding pattern, promoter holding, financials and share price
About Shanti Overseas (India) Ltd (SHANTI)
Shanti Overseas (India) Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as SHANTI and on the BSE under scrip code 538443. Its ISIN is INE933X01016.
Incorporated in 2011, Shanti Overseas India Ltd is engaged in primary processing and trading of agri commodities. [1]
Shanti Overseas (India) Ltd is a public company engaged in the manufacture and processing of soya products and other agri-commodities.
The company operates from two units in Indore, focusing on primary processing and manufacturing of products such as soya de-oiled cakes and crude oil.
Listed peers in Pesticides & Agrochemicals: Nirman Agri Genetics Ltd, Adarsh Plant Protect Ltd, Continental Seeds and Chemicals Ltd, Phyto Chem (India) Ltd, Natural Biocon (India) Ltd, PB Global Ltd.
Valuation & Returns
10 Jul 2026At ₹6.69 a share on 10 Jul 2026, Shanti Overseas (India) Ltd (SHANTI) was valued at a price-to-earnings ratio of -0.98x against an industry P/E of 22.12x and a price-to-book of 0.65x on a book value of ₹10.35 per share as of Mar 2025. Solomo computes return on equity of -66.01% and return on capital employed of -18.39% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -0.98x
- Industry P/E
- 22.12x
- P/B
- 0.65x
- EPS (TTM)
- ₹-6.83
- Book value / share
- ₹10.35
- ROE
- -66.01%
- ROCE
- -18.39%
- ROA
- -37.64%
- Debt / equity
- 0.12x
- Dividend yield
- 0%
- EBITDA margin
- -16.88%
- 52-week range
- ₹4.7 – ₹14.58
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shanti Overseas (India) Ltd (SHANTI) reported revenue of ₹13.92 crore, net profit of ₹-7.5 crore and earnings per share of ₹-6.75. That compares with revenue of ₹23.84 crore and net profit of ₹-2.79 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹6.74 crore and net profit ₹-9.26 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 202.81 | 149.33 | 10.66 | 23.84 | 13.92 |
| Net profit (₹ cr) | 3.1 | -16.9 | -1.53 | -2.79 | -7.5 |
| EPS (₹) | 2.79 | -15.22 | -1.38 | -2.51 | -6.75 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -13.79% | -31.11% | -31.27% | 123.64% |
| Profit growth | - | - | - | 82.35% |
| Stock price CAGR | - | -20% | -25% | -48% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 0% of Shanti Overseas (India) Ltd (SHANTI) (unchanged from the previous quarter). Market capitalisation was ₹7 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2017.
Largest disclosed public shareholders in Jun 2026: Nova Plasmold Private Ltd 8.28%, Mr. Shyam Lal Kharol 3.28%, Vikas Kumar Mittal 2.92%, Mahaveer Kachhara 2.73%, Dhruv Neema 1.89%, Bimalkumar Manubhai Savalia 1.81%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 0% | - | - | - | - |
| Mar 2026 | 0% | - | - | - | - |
| Dec 2025 | 0% | - | - | - | - |
| Sep 2025 | 0% | - | - | - | - |
| Jun 2025 | 3.79% | - | - | - | - |
| Mar 2025 | 6.54% | - | - | - | - |
| Dec 2024 | 9.46% | - | - | - | - |
| Sep 2024 | 52.09% | - | - | - | - |